Stereotaxis Q2 revenue misses estimates, dragged by system decline

Stereotaxis

11/08/2026 21:11

Overview
Surgical robotics firm's Q2 revenue declined yr/yr and missed analyst expectations
System revenue fell due to lack of robotic system deliveries, partly offset by Synchrony sales
Company completed previously announced Robocath acquisition, expanding endovascular technology portfolio

Outlook
Company expects recurring revenue to reach $7 mln in Q3 and $8 mln in Q4 2026
Stereotaxis projects system revenue of about $3 mln in both Q3 and Q4 2026
Company anticipates reaching cash flow profitability in the first half of 2027

Result Drivers
SYSTEM REVENUE DECLINE - Co said lack of robotic system deliveries led to lower system revenue, partly offset by initial Synchrony sales
RECURRING REVENUE GROWTH - Recurring revenue increased due to contributions from new robotic catheters, despite procedural pressure from limited catheter supply
ROBOCATH ACQUISITION - Co completed Robocath acquisition, aiming to strengthen robotic technology leadership across endovascular procedures

Company press release: ID:nGNX1lYNCD

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Miss
$7.67 mln
$8.35 mln (4 Analysts)
Q2 Net Loss
 
$4.47 mln
 
Q2 Operating Expenses
 
$9.05 mln
 
Q2 Operating Income
 
-$4.57 mln
 
Q2 Disposable, service and accesories revenue
 
$6.20 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Stereotaxis Inc is $4.00, about 177.8% above its August 10 closing price of $1.44

Reuters Recommended Reads
Aug 10 - Orchestra BioMed Q2 revenue drops, net loss widens
Aug 10 - Ceribell Q2 revenue beats estimates; raises 2026 revenue outlook
Aug 10 - Surgery Partners Q2 revenue beats on growth in same-facility segment

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)